✦ LIBER ✦

Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina

✍ Scribed by Mario Marzilli; Gianmario Sambuceti; Roberto Testa; Silvio Fedele

Book ID: 119543335
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 144 KB
Volume: 40
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(02)02590-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet glycoprotein IIb/IIIa receptor

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

✍ A.Michael Lincoff; Robert M Califf; Eric J Topol 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Coronary stenting and platelet glycoprot

Coronary stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction

✍ Giovanni M. Santoro; Leonardo Bolognese 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 332 KB

The Glycoprotein IIb/IIIa Platelet Recep

The Glycoprotein IIb/IIIa Platelet Receptor Blocker Tirofiban, but Not Heparin, Counteracts Platelet Aggregation in Unstable Angina Pectoris

✍ Eva Mattsson MD; Arne Martinsson MD; PhD; Olof Nyqvist MD; PhD; Gundars Rasmanis 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Platelet glycoprotein IIb/IIIa receptor

Platelet glycoprotein IIb/IIIa receptor antagonists and coronary artery disease

✍ Phong Nguyen-Ho; Nasser M. Lakkis 📂 Article 📅 2001 🏛 Current Science Inc. 🌐 English ⚖ 353 KB

The platelet in acute coronary syndromes

The platelet in acute coronary syndromes: defining the pivotal role of platelet glycoprotein IIb/IIIa receptor blockade

✍ Robert L. Jesse 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Platelet glycoprotein IIb/IIIa receptor

Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease

✍ Etheridge, Susan P. ;Tani, Lloyd Y. ;Minich, L. LuAnn ;Revenaugh, James R. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin. She did not